Wegovy received FDA approval for cardiovascular risk reduction in adults with known heart disease or obesity
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
On Jan. 27, 2021, researchers at the Broad Institute of MIT and Harvard, and Massachusetts General Hospitalï¾’s Center…
On Dec. 3, 2010, Banglore, India-based Opto Circuits announced completion of its merger with Bothell-based Cardiac Science Corp….
On Sept. 16, 2009, Brian J. Druker, M.D.,whose research led to the development of Gleevec, the first targeted…
On Feb. 28, 2005, Quinton Cardiology Systems and Cardiac Science announced the signing of a definitive merger agreement…
In 2005, the Penn Cardiovascular Institute (CVI) was established as a collaborative multi-disciplinary group of basic and translational…
In 2004, Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib) because of an increased risk of heart…
On Apr. 15, 2003, the National Heart Lung Blood Institute (NHLB) announced a $37 million trial, coordinated by…
On Oct. 29, 2002, an international research consortium launched a $100 million public-private effort to create the next…
On May 7, 2002, Quinton Cardiology Systems held its Initial Public Offering raising $28 million. The Bothell, Washington…
In 2001, World Heart Day, an annual event which takes place on 29 September every year, was founded….
In 2001, SynCardia Systems, a private company formed to commercialize the Jarvik 7 artificial heart, was founded by…
On Oct. 12, 1998, Louis J. Ignarro of the University of California School of Medicine was awarded the…